Comparative Pharmacology
Head-to-head clinical analysis: SOLOSEC versus VANDAZOLE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SOLOSEC versus VANDAZOLE.
SOLOSEC vs VANDAZOLE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Secnidazole is a nitroimidazole antibiotic that exerts its bactericidal activity by entering the bacterial cell and inhibiting DNA synthesis. The nitro group of secnidazole is reduced intracellularly to form free radicals and other reactive intermediates that damage bacterial DNA.
VANDAZOLE is a nitroimidazole antimicrobial agent that undergoes reduction by bacterial nitroreductases, forming cytotoxic free radicals that damage DNA and inhibit nucleic acid synthesis.
2 g orally as a single dose for trichomoniasis.
2 g orally as a single dose once daily for 2 days.
None Documented
None Documented
Terminal elimination half-life approximately 8-12 hours in patients with normal renal function; may be prolonged in renal impairment
Approximately 8-10 hours in adults; prolonged to 20-25 hours in hepatic impairment.
Renal: approximately 75% as unchanged drug; fecal/biliary: minor (estimated <10%)
Primarily renal (40-70% unchanged), with biliary/fecal elimination accounting for 15-20% as metabolites.
Category C
Category C
Nitroimidazole Antibiotic
Nitroimidazole Antibiotic